Navigation Links
Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Date:9/25/2007

- Data Sufficient to Advance Product to Pivotal Phase -

WALTHAM, Mass., Sept. 25 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. (OTC Bulletin Board: ABOS), today provided its clinical trial strategy for the SEPET(TM) Liver Assist Device including information regarding a pre-pivotal phase meeting with the US Food and Drug Administration (FDA). In a meeting held between Arbios and the FDA's Office for Device Evaluation and Research (ODE), the FDA indicated that, pending receipt of a final report, SEPET(TM) has met the required feasibility trial objectives and Arbios may advance its clinical development program to the pivotal phase. In response to the presentation of a pivotal trial design, the FDA provided the Company with comment and further indicated that a single pivotal study may be acceptable to the FDA, subject to a submission of a full clinical protocol to include additional information required in an Investigational Device Exemption (IDE) application. Arbios intends to file this information for review in the coming weeks, as a potential final step toward FDA authorization of a pivotal clinical trial for SEPET(TM).

"We are pleased with the discussion at our recent meeting with the FDA regarding our SEPET(TM) Liver Assist Device," commented Shawn Cain, Interim President and Chief Executive Officer of Arbios. "Following the results of our feasibility clinical trial, the FDA review group said that SEPET(TM) could advance into a multicenter pivotal clinical trial. We appear to be on track for near-term initiation of a pivotal registration trial of SEPET(TM) in the US."

We expect the proposed pivotal clinical trial would enroll 80 patients in the principal randomized, controlled phase of the study, targeted to achieve the primary endpoint of the trial, which is a clinically significant reduction in hepatic encephalopathy. Patients receiving SEPET(TM) treatment plus standard medical care would be compared to control patients receiving
'/>"/>

SOURCE Arbios Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
2. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
3. XTL Provides Update on Phase I Clinical Trial of XTL-2125
4. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
5. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
6. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
7. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
8. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
9. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
10. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
11. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,I...evelopingproductsforminimallydisruptivesurgicaltre...nferencecallonMonday,November30,2009,at5:30p.m.ET/...esrelativetoreimbursementfortheCompany,sproductsan...questionandanswersession.Thedial-innumbersare1-877...
(Date:11/25/2009)... NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannou...talogue: ,, PainManagement-GlobalTrends ,...gement---Global-Trends.html ,, Widespreadavail...nics,andtheadventofnewdrugshaveacceleratedthepaceo...andreimbursementstructurecontinuetoshapedemandfors...
(Date:11/25/2009)... DELFT,TheNetherlandsandJOHANNESBURG,November25/PR...andPyxisDiscoveryannouncedtoday,thattheyhavesigned...es,services. , Pyxis,sworldclasscomputational...thiThemba,sservicedivisiontoprovidemedicinaland,sy...Pyxis,internationalclientnetwork.iThembaPharmaceu...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Moderate Drinking Guards the Heart 61733 1Moderate Drinking Guards the Heart 61733 2Moderate Drinking Guards the Heart 61733 3Highlighting racial disparities increases coverage and effectiveness of health news 61731 1Highlighting racial disparities increases coverage and effectiveness of health news 61731 2Patients weight not linked to success of fibroid surgery 61729 1Patients weight not linked to success of fibroid surgery 61729 2
(Date:11/26/2009)...cations announces a highly effective and unconvent...ing to make an economic recovery. , ...is the type of challenge that could send ailing ho.... David Benton, business growth expert and author ...h; The Rfactor Intensive . “Fear is one o...
(Date:11/25/2009).../--TheBartleHallConventionCenterwilltemporarilybec...ansasCityhoststhelatestinaseriesofmassivefreeclini...sthepotentialtobethebiggestoneyet,becauseitwillext...nsteadofoveraweekend,"SheriWood,executivedirectoro...ionalAssociationofFreeClinics(NAFC). ,, Atprevi...
(Date:11/25/2009)...nelleMedicalInc.,aleadingmanufacturerofbreastMRIco...fnewleadingedgeclinicalapplicationsonitsAegis(TM)m...calSocietyofNorthAmerica(RSNA)annualmeetinginChica...onsleveragetheuniquehighqualityimagesgeneratedbySe...ipleimagingmodalitiesformulti-parametricassessment...
(Date:11/25/2009)...ewswire/--TheBlackAIDSInstituterecentlyheldBoardof...2010. ,, ThenewBoardMembersareahighlydiversegro...ce,governmenthealthprograms,editorial,andbusinesse...ersonalbackgroundsincludingbothheterosexualandgayB...resentingmultipleagegroups. ,, (Photo: http://w...
(Date:11/25/2009)...er who were treated with cisplatin-based chemother...ogical side effects and Raynaud-like phenomena, th...ording to a new study published online November 25.... , Marianne Brydy, M.D., of the Department of O... Norway, and colleagues conducted a cross-sectiona...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...of the DNC bolsters firm,s national government aff...oward Dean -- a nationally recognized political fi... -- has agreed to serve as an independent consulta...he areas of healthcare and alternative energy reso...
...lects company,s complete portfolio of Rx and speci...arch 3 Ortho-McNeil-Janssen Pharmaceuticals, Inc.... is now Ortho Dermatologics. , , The new name ...specialty aesthetic products for medical dermatolo...
...J., March 3 David B. Snow Jr., chairman and chief...NYSE: MHS ), is scheduled to address the Barclay... Wednesday, March 11, 2009. , , The presentation ... , The presentation may be heard live via a simulc...
...orts Significant Growth, Industry Leadership in In... GetWellNetwork, Inc. , the leading provider of ...nounced that it received $10 million in a Series C...luding Valhalla Partners, Grosvenor Funds, Point J...
...lif., March 3 Thoratec Corporation,(Nasdaq: THO...culatory support,therapies to save, support and re...articipating in the Raymond James 30th Annual Inst...the company, beginning at 8:05 a.m., Eastern Dayli...
...ch 3 Each day we have countless conversations wit...iscover that much of what we say to ourselves is c...m to expect perfection, and if we don,t get it, we...ok, "Conversations with Self: Discovering the Powe...
Other Medicine News:Health News:Howard Dean to Join McKenna Long and Aldridge LLP 2Health News:Howard Dean to Join McKenna Long and Aldridge LLP 3Health News:Professional Skin Care Company OrthoNeutrogena Becomes Ortho Dermatologics 2Health News:Medco CEO to Present at the Barclays Capital Global Healthcare Conference 2Health News:GetWellNetwork Closes $10 Million Financing, Eight Hospitals Choose PatientLife System(R) for Unparalleled Patient Care 2Health News:GetWellNetwork Closes $10 Million Financing, Eight Hospitals Choose PatientLife System(R) for Unparalleled Patient Care 3Health News:'Conversations with Self: Discovering the Power of Your Inner Voice': Discover How to Find and Listen to an Inner Voice That Is Encouraging and Helpful 2
Langerman Phaco Chopper
Minardi Phaco Chopper
Alio-Rosen Phaco PreChopper
Ti/HA Peg & Sleeve System
Medicine Products: